Moreover, the effect of modulating YY1 expression levels on Raji cellular growth, as well as on cellular viability following anti-cancer treatments was evaluated, confirming the pro-tumorigenic role of both YY1 and survivin in these cells. Here, BIRC5 is linked to cancer.